Sera neutralizing activities against SARS-CoV-2 and multiple variants six month after hospitalization for COVID-19

Viral Infections, Non-HIV

Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies

Viruses.

Ahmed SF, Quadeer AA, McKay MR

doi: 10.3390/v12030254.

Viral Infections, Non-HIV

Investigating SARS-CoV-2 surface and air contamination in an acute healthcare setting during the peak of the COVID-19 pandemic in London

Clin Infect Dis.

Zhou J, Otter JA, Price JR, Cimpeanu C, Garcia DM, Kinross J, Boshier PR, Mason S, Bolt F, Holmes AH, Barclay WS

doi: 10.1093/cid/ciaa905.

Viral Infections, Non-HIV

Absence of SARS-CoV-2 in Semen of a COVID-19 Patient Cohort

Andrology.

Guo L, Zhao S, Li W, Wang Y, Li L, Jiang S, Ren W, Yuan Q, Zhang F, Kong F, Lei J, Yuan M

doi: 10.1111/andr.12848.

Viral Infections, Non-HIV

Incidental COVID-19 in a Heart-Kidney Transplant Recipient with Malnutrition and Recurrent Infections: Implications for the SARS-CoV-2 Immune Response

Transpl Infect Dis.

Serrano OK, Kutzler HL, Rochon C, Radojevic JA, Lawlor MT, Hammond JA, Gluck J, Feingold AD, Jaiswal A

doi: 10.1111/tid.13367.

Viral Infections, Non-HIV

Abdominal Surgery in Patients with COVID-19: Detection of SARS-CoV-2 in Abdominal and Adipose Tissues

Ann Surg.

Safari S, Keyvani H, Alamdari NM, Dehghanian A, Hashemi MR, Honar BN, Aminian A

doi: 10.1097/SLA.0000000000004165.

Viral Infections, Non-HIV

Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation

J Clin Virol.

Jääskeläinen AJ, Kuivanen S, Kekäläinen E, Ahava MJ, Loginov R, Kallio-Kokko H, Vapalahti O, Jarva H, Kurkela S, Lappalainen M

doi: 10.1016/j.jcv.2020.104512.

Viral Infections, Non-HIV

Detecting SARS-CoV-2 RNA in conjunctival secretions: is it a valuable diagnostic method of COVID-19?

J Med Virol.

Güemes-Villahoz N, Burgos-Blasco B, Vilela AA, Arriola-Villalobos P, Luna CMR, Sardiña RC, Delgado-Iribarren A, García-Feijoó J

doi: 10.1002/jmv.26219.

Further Publications Infectiology

Plasma from post-COVID-19 and COVID-19-Vaccinated Donors Results in Highly Potent SARS-CoV-2 Neutralization by Intravenous Immunoglobulins

J Infect Dis

Karbiener M, Farcet MR, Schwaiger J, Powers N, Lenart J, Stewart JM, Tallman H, Kreil TR

doi: 10.1093/infdis/jiab482

Viral Infections, Non-HIV

The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the Cause of COVID-19

Protein J.

Yoshimoto FK

doi: 10.1007/s10930-020-09901-4.

Related content

Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies

Investigating SARS-CoV-2 surface and air contamination in an acute healthcare setting during the peak of the COVID-19 pandemic in London

Absence of SARS-CoV-2 in Semen of a COVID-19 Patient Cohort

Incidental COVID-19 in a Heart-Kidney Transplant Recipient with Malnutrition and Recurrent Infections: Implications for the SARS-CoV-2 Immune Response

Abdominal Surgery in Patients with COVID-19: Detection of SARS-CoV-2 in Abdominal and Adipose Tissues

Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation

Detecting SARS-CoV-2 RNA in conjunctival secretions: is it a valuable diagnostic method of COVID-19?

Plasma from post-COVID-19 and COVID-19-Vaccinated Donors Results in Highly Potent SARS-CoV-2 Neutralization by Intravenous Immunoglobulins

The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the Cause of COVID-19